Cargando…

SUN-194 Erasing the Methyl Mark: Mechanism of Androgen Action in the Ovary

Androgen actions through androgen receptor (AR) are critical for follicle growth and female fertility. While excess androgen level leads to polycystic ovary syndrome (PCOS), a certain amount of direct androgen action is critical for normal ovarian function. Thus, with respect to androgen actions in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Sambit, Sen, Aritro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553050/ http://dx.doi.org/10.1210/js.2019-SUN-194

Ejemplares similares

OR31-04 Androgen Signaling Regulates Female Fertility Through Modulation of H3K27me3 in Granulosa Cells
por: Roy, Sambit, et al.
Publicado: (2020)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome
por: Cox, Madeleine J, et al.
Publicado: (2020)

SUN-LB4 Androgenic Profiles of Patients With Severe Insulin Resistance
por: Jha, Smita, et al.
Publicado: (2020)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

OR08-2 Androgen Receptor- Vs Estrogen Receptor-Mediated Actions in the Development of Distinct Clinical Polycystic Ovary Syndrome (PCOS) Phenotypes
por: Aflatounian, Ali, et al.
Publicado: (2019)

SUN-038 Social and Psychological Aspects of Partial Androgen Insensitivity Syndrome, Therapeutic Challenges
por: Masood, Faryal T, et al.
Publicado: (2020)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

SUN-230 Association of Estrogens and Androgens with Sexual Function after Hematopoietic Stem Cell Transplant
por: Anderson, Lindsey, et al.
Publicado: (2019)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SUN-025 Obesity Severity and Polycystic Ovary Syndrome in an Ethnically Diverse Cohort of Adolescent Girls
por: Khil, Jaclyn, et al.
Publicado: (2020)

Androgen Action in the Ovary
por: Franks, Stephen, et al.
Publicado: (2018)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

SUN-020 Waist Circumference Is Associated with Insulin Resistance in Young Korean Women with Polycystic Ovary Syndrome
por: Song, Do Kyeong, et al.
Publicado: (2020)

SUN-LB038 Rate and Extent of Testicular Function Recovery after Ceasing Non-Prescribed Androgen Abuse
por: Shankara Narayana, Nandini, et al.
Publicado: (2019)

SUN-LB5 GnRHR ECL-2 Epitopes Targeted by Activating Autoantibodies in Polycystic Ovary Syndrome
por: Guo, Yankai, et al.
Publicado: (2020)

SAT-194 Correlation of Capillary and Venous Plasma Measurements of Anti-Müllerian Hormone
por: Adams, Hadar, et al.
Publicado: (2019)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

SUN-LB042 The Novel Androgen 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) Effectively Suppresses Gonadotropins and Testosterone in Healthy Men: A Potential Oral Male Hormonal Contraceptive
por: Yuen, Fiona, et al.
Publicado: (2019)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

SUN-193 Effects of Aldosterone on Ovarian Steroidogenesis and Involvement of BMP Action in Rat Granulosa Cells
por: Nakano, Yasuhiro, et al.
Publicado: (2019)

SUN-022 Metformin-Fish Oil Adjunct Therapy Improves apoB-Remnant Lipoprotein and Triglyceride Levels in Women with Polycystic Ovary Syndrome
por: Proctor, Ethan, et al.
Publicado: (2020)

SUN-010 Efficacy of High Intensity Intermittent Training for Improving Cardio-Metabolic Health in Women with Polycystic Ovary Syndrome: A Pilot Study
por: Patten, Rhiannon Kate, et al.
Publicado: (2020)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

FRI383 Androgen Receptor Signaling Regulates Follicular Growth And Steroidogenesis In The Ovary In Interaction With Gonadotropins During Mini-puberty In Mice
por: Devillers, Marie, et al.
Publicado: (2023)

SUN-016 Mendelian Randomization Reveals That Polycystic Ovary Syndrome Is Not a Causal Risk Factor for Type 2 Diabetes, Coronary Heart Disease, or Stroke
por: Zhu, Tiantian, et al.
Publicado: (2020)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome
por: Hoyos, Luis R, et al.
Publicado: (2020)

SUN-LB039 Novel Use of Thromboelastography (TEG) to Investigate the Prothrombotic Effects of Testosterone Replacement Therapy (TRT) for Androgen Deficiency (AD) Established with Diagnostic Rigor (DR)
por: Subramaniam, Shreya, et al.
Publicado: (2019)

OR35-05 Interaction of Cortisol with Testosterone Predicts Abdominal Fat Mass in Normal-weight Polycystic Ovary Syndrome Women with Normal Serum 11-Oxygenated Androgens
por: Anthony Dumesic, Daniel, et al.
Publicado: (2023)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

MON-194 Multidisciplinary Care for Adult Transgender/Gender Non-binary Patients: A Novel Healthcare Delivery Model Centered within the Endocrinology Clinic
por: Iwamoto, Sean, et al.
Publicado: (2019)

SUN-196 Generation of Potent Inhibin Analogues
por: Goney, Monica, et al.
Publicado: (2019)

SUN-224 Testosterone Reduces Expression of Inflammatory Targets in Human Macrophages as a Potential Mechanism to Improve Atherosclerosis
por: Bateman, Lauren, et al.
Publicado: (2019)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce10slp7nbcl8c1f6auk8ep8id